Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: Generation of NF-κB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation

EMBO Journal

Volumn 16, Issue 12, 1997, Pages 3609-3620

  Watanabe, Nobumasa ^a   Iwamura, Tomokatsu ^a   Shinoda, Tatsuya ^a,b   Fujita, Takashi ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

BCL 3; NF B; Nuclear translocation; Transcription factor

Indexed keywords

DIMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; CYTOPLASM; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ANIMALS; B-LYMPHOCYTES; BIOLOGICAL TRANSPORT; CELL LINE; CELL NUCLEUS; CYTOPLASM; DIMERIZATION; DNA; ENDOPEPTIDASES; GENE EXPRESSION; MICE; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS; RABBITS; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0030988261     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.12.3609     Document Type: Article

References (53)

1. Baeuerle, P.A. (1991) The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim. Biophys. Acta, 1072, 63-80.
2. Baeuerle, P.A. and Henkel, T. (1994) Function and activation of NF-κB in the immune system. Annu. Rev. Immunol., 12, 141-179.
3. Beg, A.A. and Baltimore, D. (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science, 274, 782-784.
4. Betts, J.C. and Nabel, G.J. (1996) Differential regulation of NF-κB2(p100) processing and control by amino-terminal sequences. Mol. Cell. Biol., 16, 6363-6371.
5. Bhatia, K., Huppi, K., McKeithan, T., Siwarski, D., Mushinski, J.F. and Magrath, I. (1991) Mouse bcl-3: cDNA structure, mapping and stage-dependent expression in B lymphocytes. Oncogene, 6, 1569-1573.
6. Blank, V., Kourilsky, P. and Israel, A. (1991) Cytoplasmic retention, DNA binding and processing of the NF-κB p50 precursor are controlled by a small region in its C-terminus. EMBO J., 10, 4159-4167.
7. Blank, V., Kourilsky, P. and Israel, A. (1992) NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem. Sci., 17, 135-140.
8. Bours, V., Franzoso, G., Azarenko, V., Park, S., Kanno, T., Brown, K. and Siebenlist, U. (1993) The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell, 72, 729-739.
9. Caamano, J.H., Perez, P, Lira, S.A. and Bravo, R. (1996) Constitutive expression of Bcl-3 in thymocytes increases the DNA binding of NF-κB1 (p50) homodimers in vivo. Mol. Cell. Biol., 16, 1342-1348.
10. Franzoso, G., Bours, V., Park, S., Tomita-Yamaguchi, M., Kelly, K. and Siebenlist, U. (1992) The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature, 359, 339-342.
11. Franzoso, G., Bours, V., Azarenko, V. Park, S., Tomita, Y.M., Kanno, T., Brown, K. and Siebenlist, U. (1993) The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select κB sites. EMBO J., 12, 3893-3901.
12. Fujita, T. Nolan, G.P., Ghosh, S. and Baltimore, D. (1992) Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB. Genes Dev., 6, 775-787.
13. Fujita, T., Nolan, G.P., Liou, H.C., Scott, M.L. and Baltimore, D. (1993) The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev., 7, 1354-1363.
14. Ghosh, S., Gifford, A.M., Riviere, L.R., Tempst, P., Nolan, G.P. and Baltimore, D. (1990) Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell, 62, 1019-1029.
15. Harlow, H. and Lane, D. (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
16. Haskill, S., Beg, A.A., Tompkins, S.M., Morris, J.S., Yurochko, A.D., Sampson-Johannes, A., Mondal, K., Ralph, P. and Baldwin Jr,A.S. (1991) Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell, 65, 1281-1289.
17. Hatada, E.N., Nieters, A., Wulczyn, F.G., Naumann, M., Meyer, R., Nucifora, G., McKeithan, T.W. and Scheidereit, C. (1992) The ankyrin repeat domains of the NF-κB precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-κB DNA binding. Proc. Natl Acad. Sci. USA, 89, 2489-2493.
18. Hatada, E.N., Naumann, M. and Scheidereit, C. (1993) Common structural constituents confer IκB activity to NF-κB p 105 and IκB/MAD-3. EMBO J., 12, 2781-2788.
19. Henkel, T., Zabel, U., van Zee, K., Muller, J. M., Fanning, E. and Baeuerle, P.A. (1992) Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit. Cell, 68, 1121-1133.
20. Kerr, L.D., Duckett, C.S., Wamsley, P., Zhang, Q., Chiao, P., Nabel, G., McKeithan, T.W., Baeuerle, P.A. and Verma, I.M. (1992) The proto-oncogene bcl-3 encodes an IκB protein. Genes Dev., 6, 2352-2363.
21. Kieran, M., Blank, V., Logeat, F., Vandekerckhove, J., Lottspeich, F., Le Bail, O., Urban, M.B., Kourilsky, P., Baeuerle, P.A. and Israel, A. (1990) The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell, 62, 1007-1018.
22. Lankester, A.C., van Schijndel, G.M.W., van der Schoot, C.E., van Oers, M.H.J., van Noesel, C.J.M. and van Lier, R.A.W. (1995) Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells. Blood, 86, 1090-1097.
23. Lin, L. and Ghosh, S. (1996) A glycine-rich region in NF-κB p105 functions as a processing signal for the generation of the p50 subunit. Mol. Cell. Biol., 16, 2248-2254.
24. Liou, H.-C., Nolan, G.P., Ghosh, S., Fujita, T. and Baltimore, D. (1992) The NF-κB p50 precursor, p105, contains an internal IκB-like inhibitor that preferentially inhibits p50. EMBO J., 11, 3003-3009.
25. Liou, H.-C., Sha, W. C., Scott, M.L. and Baltimore, D. (1994) Sequential induction of NF-κB/Rel family proteins during B-cell terminal differentiation. Mol. Cell Biol., 14, 5349-5359.
26. Liu, Z.-G., Hsu, H., Goeddel, D.V. and Kann, M. (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell, 87, 565-576.
27. McKeithan, T.W., Ohno, H. and Diaz, M.O. (1990) Identification of a transcriptional unit adjacent to the breakpoint in the 14;19 translocation of chronic lymphocytic leukemia. Genes Chromosomes Cancer, 1, 247-255.
28. Mercurio, F. DiDonato, J.A., Rosette, C. and Karin, M. (1993) p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev., 7, 705-718.
29. Mizushima, S. and Nagata, S. (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res., 18, 5322.
30. Naumann, M., Nieters, A., Hatada, E.N. and Scheidereit, C. (1993a) NF-κB precursor p100 inhibits nuclear translocation and DNA binding of NF-κB/rel-factors. Oncogene, 8, 2275-2281.
31. Naumann, M., Wulczyn, F.G. and Scheidereit, C. (1993b) The NF-κB precursor p105 and the proto-oncogene product Bcl-3 are IκB molecules and control nuclear translocation of NF-κB. EMBO J., 12, 213-222.
32. Nolan, G.P. and Baltimore, D. (1992) The inhibitory ankyrin and activator Rel proteins. Curr. Opin. Genet. Dev., 2, 211-220.
33. Nolan, G.P., Fujita, T., Bhatia, K., Huppi, C., Liou, H.C., Scott, M.L. and Baltimore, D. (1993) The bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner. Mol. Cell. Biol., 13, 3557-3566.
34. Ohno, H., Takimoto, G. and McKeithan, T.W. (1990) The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell, 60, 991-997.
35. Palacios, R., Karasuyama, H. and Rolink, A. (1987) Ly1+ pro-B lymphocyte clones. Phenotype, growth requirements and differentiation in vitro and in vivo. EMBO J., 6, 3687-3693.
36. Palombella, V.J., Rando, O.J., Goldberg, A.L. and Maniatis, T. (1994) The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell, 78, 773-785.
37. Pear, W.S., Nolan, G.P., Scott, M.L. and Baltimore, D. (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA, 90, 8392-8396.
38. Rice, N.R., MacKichan, M.L. and Israel, A. (1992) The precursor of NF-κB p50 has IκB-like functions. Cell, 71, 243-253.
39. Schmid, R.M., Perkins, N.D., Duckett, C.S., Andrews, P.C. and Nabel, G.J. (1991) Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65. Nature, 352, 733-736.
40. Schmitz, M.L. and Baeuerle, P.A. (1991) The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J., 10, 3805-3817.
41. Schreiber, E., Matthias, P. Muller, M.M. and Schaffner, W. (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res., 17, 6419.
42. Scott, M.L., Fujita, T., Liou, H.C. Nolan, G.P. and Baltimore, D. (1993) The p65 subunit of NF-κB regulates IκB by two distinct mechanisms. Genes Dev., 7, 1266-1276.
43. Shibuya, H., Yoneyama, M. Ninomiya-Tsuji, J., Matsumoto, K. and Taniguchi, T. (1992) IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell. 70, 57-67.
44. + T cells express perturbed AP-1 and NF-κB transcription factors. Proc. Natl Acad. Sci. USA, 93, 979-984.
45. Ten, R.M, Paya, C.V., Israel, N., Le Bail, O., Mattei, M.-G., Virelizier, J.-L., Kourilsky, P. and Israel, A. (1992) The characterization of the promoter of the gene encoding the p50 subunit of NF-κB indicates that it participates in its own regulation. EMBO J., 11, 195-203.
46. Thompson, J.E., Phillips, R.J., Erdjument-Bromege, H., Tempst, P. and Ghosh, S. (1995) IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell, 80, 573-582.
47. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R. and Verma, I.M. (1996) Suppression of TNF-α-induced apoptosis by NF-κB. Science, 274, 787-789.
48. Verma, I.M., Stevenson, J.K., Schwarz, E.M., Van Antwerp, D. and Miyamoto, S. (1995) Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev., 9, 2723-2735.
49. Wang, C.-Y., Mayo, M.W. and Baldwin Jr,A.S. (1996) TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science, 274, 784-787.
50. Wulczyn, F.G., Naumann, M. and Scheidereit, C. (1992) Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB. Nature, 358, 597-599.
51. Zabel, U. and Baeuerle, P.A. (1990) Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell, 61, 255-265.
52. Zhang, Q., DiDonato, J.A., Karin, M. and McKeithan, T.W. (1994) BCL3 encodes a nuclear protein which can alter the subcellular location of NF-κB proteins. Mol. Cell. Biol., 14, 3915-3926.
53. Ziegler-Heitbrock, H.W.L., Wedel, A., Schraut, W., Strobel, M., Wendelgass, P. Stemsdorf, T., Baeuerle, P.A., Haas, J.G. and Riethmuller, G. (1994) Tolerance to lipopolysaccharide involves mobilization of nuclear factor κB with predominance of p50 homodimers. J. Biol. Chem., 269, 17001-17004.